Evidence map›Paper›PMID 26961881›Full record

ArticleThe Journal of biological chemistry2016

Different Roles of Negative and Positive Components of the Circadian Clock in Oncogene-induced Neoplastic Transformation.

Chiharu Katamune, Satoru Koyanagi, Shoya Shiromizu, Naoya Matsunaga, Shigeki Shimba, Shigenobu Shibata, Shigehiro Ohdo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Cancer, hear my battle CRY.Journal of pineal research · 2020
    Review
  8. Article
  9. Article
  10. Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism.Trends in endocrinology and metabolism: TEM · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chiharu KatamuneFrom the Department of Pharmaceutics and.
Satoru KoyanagiDepartment of Glocal Healthcare Science, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Shoya ShiromizuFrom the Department of Pharmaceutics and.
Naoya MatsunagaFrom the Department of Pharmaceutics and.
Shigeki ShimbaDepartment of Health Science, School of Pharmacy, Nihon University, Funabashi 274-8555, Japan, and.
Shigenobu ShibataLaboratory of Physiology and Pharmacology, School of Advanced Science and Engineering, Waseda University Tokyo, 162-0056, Japan.
Shigehiro OhdoFrom the Department of Pharmaceutics and ohdo@phar.kyushu-u.ac.jp.
Kyushu University · JPNihon University · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In mammals, circadian rhythms in physiological function are generated by a molecular oscillator driven by transcriptional-translational feedback loop consisting of negative and positive regulators. Disruption of this circadian clock machinery is thought to increase the risk of cancer development, but the potential contributions of each component of circadian clock to oncogenesis have been little explored. Here we reported that negative and positive transcriptional regulators of circadian feedback loop had different roles in oncogene-induced neoplastic transformation. Mouse embryonic fibroblasts prepared from animals deficient in negative circadian clock regulators, Period2 (Per2) or Cryptochrome1/2 (Cry1/2), were prone to transformation induced by co-expression of H-ras(V12) and SV40 large T antigen (SV40LT). In contrast, mouse embryonic fibroblasts prepared from mice deficient in positive circadian clock regulators, Bmal1 or Clock, showed resistance to oncogene-induced transformation. In Per2 mutant and Cry1/2-null cells, the introduction of oncogenes induced expression of ATF4, a potent repressor of cell senescence-associated proteins p16INK4a and p19ARF. Elevated levels of ATF4 were sufficient to suppress expression of these proteins and drive oncogenic transformation. Conversely, in Bmal1-null and Clock mutant cells, the expression of ATF4 was not induced by oncogene introduction, which allowed constitutive expression of p16INK4a and p19ARF triggering cellular senescence. Although genetic ablation of either negative or positive transcriptional regulators of the circadian clock leads to disrupted rhythms in physiological functions, our findings define their different contributions to neoplastic cellular transformation.

Indexed as

OncogenesActivating Transcription Factor 4AnimalsARNTL Transcription FactorsCell MovementCell Transformation, NeoplasticCellular SenescenceCircadian ClocksCLOCK ProteinsCryptochromesMiceMice, Inbred ICRMice, Inbred NODMice, KnockoutMice, Mutant StrainsMice, SCIDActivating Transcription Factor 4ARNTL Transcription FactorsAtf4 protein, mouseBmal1 protein, mouseClock protein, mouseCLOCK ProteinsCry1 protein, mouseCry2 protein, mouseCryptochromesMutant ProteinsPer2 protein, mousePeriod Circadian Proteinscellular senescencecircadian rhythmclock geneoncogenetumor cell biology

Identifiers

PMID26961881
PMCPMC4865904
OpenAlexW2293777235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.